Renata S Auriemma Selected Research

Cabergoline

1/2021	Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment.
1/2019	Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas.
1/2018	The effects of hyperprolactinemia and its control on metabolic diseases.
1/2017	Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly.
1/2016	The safety of treatments for prolactinomas.
3/2015	Cabergoline use for pituitary tumors and valvular disorders.
1/2015	Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas.
9/2013	Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas.
1/2013	Effect of cabergoline on metabolism in prolactinomas.
1/2013	Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata S Auriemma Research Topics

Disease

24	Acromegaly 03/2017 - 09/2005
11	Neoplasms (Cancer) 09/2021 - 03/2006
8	Prolactinoma (Prolactinomas) 09/2021 - 01/2013
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 05/2010
5	Insulin Resistance 01/2019 - 03/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2013
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 09/2005
3	Hypertension (High Blood Pressure) 10/2009 - 10/2005
2	Hyperprolactinemia 01/2019 - 01/2013
2	Diabetes Mellitus 02/2017 - 02/2009
2	Cardiomyopathies (Cardiomyopathy) 07/2008 - 01/2006
1	Infertility (Sterility) 09/2021
1	Amenorrhea 09/2021
1	Thrombosis (Thrombus) 01/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	COVID-19 01/2021
1	Uterine Diseases (Endometrial Disease) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Obesity 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 02/2017
1	Respiratory Insufficiency (Respiratory Failure) 02/2017
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Optic Nerve Diseases (Optic Neuropathy) 01/2016
1	Stroke (Strokes) 01/2016
1	Nausea 08/2015
1	Hyperglycemia 08/2015
1	Erythema 08/2015
1	Gallstones (Gallstone) 08/2015
1	Diarrhea 08/2015
1	Vomiting 08/2015
1	Abdominal Pain (Pain, Abdominal) 08/2015
1	Cushing Syndrome 07/2014
1	Parkinson Disease (Parkinson's Disease) 09/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2011
1	Hypercalcemia (Milk Alkali Syndrome) 08/2011
1	Dyslipidemias (Dyslipidemia) 10/2009
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2009
1	Arthralgia (Joint Pain) 08/2009
1	Glucose Intolerance 02/2009
1	Polyps 10/2007
1	Colonic Neoplasms (Colon Cancer) 10/2007
1	Adenomatous Polyps 10/2007
1	Adenoma (Adenomas) 10/2007
1	Adenocarcinoma 10/2007

Drug/Important Bio-Agent (IBA)

14	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2017 - 09/2005
14	Insulin-Like Growth Factor I (IGF-1)IBA 06/2016 - 09/2005
10	Cabergoline FDA LinkGeneric 01/2021 - 01/2013
10	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2006
8	Octreotide (Sandostatin)FDA LinkGeneric 06/2016 - 03/2006
7	Dopamine Agonists (Dopamine Agonist)IBA 09/2021 - 01/2016
7	lanreotide (Somatuline)FDA Link 06/2016 - 03/2006
5	LipidsIBA 01/2018 - 07/2008
5	Growth Hormone (Somatotropin)IBA 07/2014 - 01/2006
4	Insulin (Novolin)FDA Link 01/2019 - 10/2007
4	pegvisomant FDA LinkGeneric 03/2017 - 03/2006
3	Testosterone (Sustanon)FDA Link 01/2019 - 01/2015
3	Hormones (Hormone)IBA 02/2017 - 03/2015
2	ProlactinIBA 09/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2008
2	Bromocriptine (Parlodel)FDA LinkGeneric 01/2019 - 01/2018
2	pasireotideIBA 04/2016 - 08/2015
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2014
1	CalciumIBA 08/2011
1	Parathyroid Hormone (Parathormone)IBA 08/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2011
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 02/2007

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2006
1	Radiotherapy 01/2016
1	Aftercare (After-Treatment) 08/2009
1	Drug Therapy (Chemotherapy) 01/2006